Scientists deploy CRISPR to preserve photoreceptors in mice

March 14, 2017, National Eye Institute
Green fluorescence indicating Nrl gene expression in mouse retina. Upper panel showing normal Nrl expression. Bottom panel showing reduced Nrl expression when knocked down with CRISPR. Credit: Zhijian Wu and Anand Swaroop

Silencing a gene called Nrl in mice prevents the loss of cells from degenerative diseases of the retina, according to a new study. The findings could lead to novel therapies for preventing vision loss from human diseases such as retinitis pigmentosa. The study was conducted by researchers at the National Eye Institute (NEI), part of the National Institutes of Health, and was published online today in Nature Communications.

The tissue in the back of the eye called the retina contains two types of cells that convert light into electrical signals sent to the brain. Rod photoreceptors enable vision in dim light, while cone photoreceptors enable and the ability to see in well-lit conditions. Genetic mutations affect mostly rods, leading to night blindness such as that seen with . However, because rods also provide vital structural and nutritional support to cones, rod dysfunction or death can lead to cone degeneration and blindness.

In a series of studies, Anand Swaroop, Ph.D., chief of NEI's Neurodegeneration and Repair Laboratory, and his team asked if saving rods could prevent the loss of cones, thus preserving daylight and color vision.

During development, Nrl determines whether a photoreceptor precursor cell becomes a rod or a cone. In previous studies, Swaroop and colleagues showed that mice engineered to lack the Nrl gene develop cone-only retinas. Other researchers showed that if Nrl expression is knocked out in rods of mature mice, the cells gain cone-like features and survive despite rod gene mutations.

"The evidence suggested to us that coaxing rods into becoming more cone-like by knocking out Nrl was a potential strategy for overriding mutations that would otherwise lead to rod degeneration," said Swaroop. "Consequently, the neighboring cones would remain functional and viable."

To test the strategy, the researchers used a new genome editing technology called CRISPR, which stands for clustered regularly interspaced short palindromic repeats. CRISPR is like a molecular pair of scissors that can be programmed to snip a specific DNA sequence with precision.

NEI postdoctoral research fellow and the study's first author, Wenhan Yu, Ph.D., developed a method for applying CRISPR in photoreceptors. His strategy uses an adeno-associated virus (AAV) as a carrier, or vector, to introduce CRISPR into . Yu tested this genome editing tool to remove the Nrl gene in wild-type mice and three different mouse models of . By measuring gene expression and examining the retinal cells, the researchers confirmed that rods became more cone-like, as predicted. Although these cone-like rods could not detect light, they survived and improved survival of their neighboring cones.

In all three mouse models, rod degeneration was prevented or slowed, although less benefit was achieved when the therapy was introduced in older animals. Importantly, the benefit was evident in all three models, regardless of the specific gene defect in the mouse.

"Unlike conventional gene therapy, in which a normal gene is introduced to replace the defective gene, this approach could treat retinal degeneration caused by a variety of mutant ," explained Zhijian Wu, Ph.D., head of the NEI Ocular Gene Therapy Core and senior author of the study.

More research is needed before the therapy is ready for testing in a clinical trial. The safety of CRISPR has yet to be established and information is needed about its possible adverse effects. Nevertheless, these findings provide proof of concept for CRISPR-based therapies for degenerative retinal diseases.

Explore further: Fighting blindness: Scientists bring a key protein into focus

More information: Yu W, Mookherjee S, Chaitankar V, Hiriyanna S, Kim JW, Brooks M, Ataeijiannati Y, Sun X, Dong L, Li T, Swaroop A, Wu Z. 2017. Nrl knockdown by AAV-delivered CRISPR/Cas9 prevents retinal degeneration in mice. Nature Communications.

Related Stories

Fighting blindness: Scientists bring a key protein into focus

March 6, 2017
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have discovered how a protein called α2δ4 establishes proper vision. Their research helps explain why mutations in the gene encoding α2δ4 lead ...

Altering eye cells may one day restore vision

January 25, 2013
(Medical Xpress)—Doctors may one day treat some forms of blindness by altering the genetic program of the light-sensing cells of the eye, according to scientists at Washington University School of Medicine in St. Louis.

Retinitis pigmentosa may be treated by reprogramming sugar metabolism

November 14, 2016
Columbia University Medical Center (CUMC) researchers have demonstrated that vision loss associated with a form of retinitis pigmentosa (RP) can be slowed dramatically by reprogramming the metabolism of photoreceptors, or ...

Retinitis pigmentosa gene discovery may reveal a new route to inherited blindness

November 24, 2016
Researchers at UCL Institute of Ophthalmology and Moorfields Eye Hospital with funding from Fight for Sight, in collaboration with a team from Baylor College of Medicine in the USA, have discovered a new retinitis pigmentosa ...

Eye's recycling process key to seeing color, bright light

October 28, 2015
As many of us learned in high school science class, the retina's rods and cones allow us to see. Rods are for night vision, and cones operate in bright light and allow us to distinguish colors. But although scientists have ...

Recommended for you

In effort to treat rare blinding disease, researchers turn stem cells into blood vessels

February 13, 2018
People who inherit a mutated version of the ATF6 gene are born with a malformed or missing fovea, the eye region responsible for sharp, detailed vision. From birth, their vision is severely limited, and there is no cure. ...

Antioxidant therapy prevents devastating vision loss when added to standard-of-care on rare birth defect

February 5, 2018
A new study led by vision researchers at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo and VA Western New York Healthcare System has demonstrated that the addition of widely available ...

Genetic basis for glaucoma uncovered

January 30, 2018
In two recent publications, Northwestern Medicine scientists and international collaborators discovered mutations that cause improper drainage and a buildup of ocular pressure leading to one form of congenital glaucoma, and ...

Study advances gene therapy for glaucoma

January 16, 2018
While testing genes to treat glaucoma by reducing pressure inside the eye, University of Wisconsin-Madison scientists stumbled onto a problem: They had trouble getting efficient gene delivery to the cells that act like drains ...

New study offers added hope for patients awaiting corneal transplants

January 9, 2018
New national research led by Jonathan Lass of Case Western Reserve University School of Medicine has found that corneal donor tissue can be safely stored for 11 days before transplantation surgery to correct eye problems ...

Diabetic blindness caused and reversed "trapped" immune cells in rodent retinas

January 3, 2018
Johns Hopkins researchers have discovered a cell signaling pathway in mice that triggers vision loss in patients with diabetic retinopathy and retinal vein occlusion – diseases characterized by the closure of blood vessels ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.